Top Markets
Coin of the day
InDex Pharmaceuticals Holding AB (publ) InDex Pharmaceuticals Holding AB (publ)

InDex Pharmaceuticals Holding AB (publ)

INDEX
Rangering i aksjer #28996
InDex Pharmaceuticals Holding AB (publ) is a pharmaceutical firm dedicated to... InDex Pharmaceuticals Holding AB (publ) is a pharmaceutical firm dedicated to developing therapeutic solutions for patients affected by ulcerative colitis. The company's flagship drug candidate, Cobitolimod, is presently in Phase III clinical trials, targeting the treatment of moderate to severe ulcerative colitis. Furthermore, InDex is progressing a pipeline of other DNA-based immunomodulatory sequences, which are in the preclinical phase, designed to address various immunological conditions. This enterprise was established in 2000 and operates from its headquarters in Solna, Sweden.
Aksjekurs
$0.04406501
Sist synkronisert: 2024-07-09
Markedsverdi
$23.47M
Endring (1 dag)
-0.48%
Endring (1 år)
0.00%
Land
SE
Handel InDex Pharmaceuticals Holding AB (publ) (INDEX)

Kategori

Aksjeprishistorikk for InDex Pharmaceuticals Holding AB (publ) (INDEX)
Høyeste sluttskurs: $0.04 den 2024-07-01

Laveste sluttskurs: $0.27 den 2016-10-01
Aksjeprishistorikk for InDex Pharmaceuticals Holding AB (publ) fra 2016 til 2026
Årlig aksjeprisytelse
År Ytelse
2024 87.14%
2023 -26.23%
2022 -50.30%
2021 -15.30%
2020 -67.25%
2019 -14.75%
2018 30.01%
2017 -11.67%
2016 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$552.07 41.28%
US
$168.77 504.69%
US
$1.03K 57.19%
NL
$117.42 -19.34%
AU
$753.28 8.59%
CH